Work

A phase II open-label, single-arm study to evaluate the efficacy of pembrolizumab for leukoplakia.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.10544

Authors: Maria Antonia Velez Velez, Thu Ly, Wanxing Chai-Ho, Mark Stephen Swanson, Meetal Dharia, Eliot Abemayor, Marilene B. Wang, Robert Kaida Chin, Allen S. Ho, Diana Messadi, Joel Epstein, James Miranda, Arturo Villanueva, Nabilah Abdelaal, Deborah J.L. Wong

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of California, Irvine, Cedars-Sinai Medical Center

Language: English

Topic: Oral Health Pathology and Treatment

Subfield: Periodontics

Field: Dentistry

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162560285

Cites:

Cited by:

Related to: